Ironically, the payers are making no mention of extending the lives of patients with CV disease nor the impact of reducing heart attacks and strokes to healthcare costs.
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
John LaMattina, Contributor, Forbes
Fri, 08/28/2015 - 3:08pm
Topics: cv
BING NEWS:
- Democrats ramp up patent fight with drug industry in bid to lower prices
Two prominent congressional Democrats this week wrote to eight pharmaceutical company CEOs, urging them to remove 130 patents from a government registry.
06/7/2024 - 5:00 am | View Link - Why Prescription Drug Prices in the US Are So High
Not only do Americans spend more than everybody else, the gap keeps widening. But there's a chance that might change.
06/6/2024 - 2:00 am | View Link - Drug-Pricing Strategies to Reduce Financial Burdens of Immunotherapy
That strategy often limits access to new, targeted therapies, even when these drugs ... drug exceeded official cost-effectiveness thresholds for all four analyzed countries: the United States, Brazil, ...
05/30/2024 - 1:00 pm | View Link - Which Statin Is Safest?
It’s best to talk with a doctor about the risks and benefits of statin therapy and possible drug interactions. Statins approved for use the in United States include: The specific medication a ...
05/27/2024 - 1:00 pm | View Link - Patent reform could be the next big move on drug pricing
After pitched battles over Medicare drug price negotiations, Congress may be pivoting to more bipartisan ground: overhaul of the patent system that allows brand-name drugs to delay competition for ...
05/21/2024 - 10:30 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more